Public court records · Regulatory sources · Independently maintained Data as of: 2026-09-29 · Not legal advice

Sanofi

pharma · Ticker: SNY, SAN.PA · 1 tracked matter · Last verified:

About the company

The company profile is sourced from neutral references (Wikipedia, official filings) so this page stays a reference, not an opinion. Our own coverage is in the regulatory history and cases below.

Violations & regulatory history

DateRegulatorTypeFine
Sep 17, 2024French courts (class action)Depakine/valproate — birth-defect compensation orders
In the first French class action, the Paris court found Sanofi liable to families over valproate (Depakine) birth defects, with individual compensation orders (e.g., a Béziers court ordered €285,000 to one mother, per BMJ, Sep 2024).
—

Cases we track

Frequently asked questions

What cases is Sanofi involved in?

We currently track 1 matter involving Sanofi: Depakine Valproate Class Action (Sanofi). Each links to the full case record with court, status and settlement information.

What has the regulator found about Sanofi?

Our regulatory history table lists 1 recorded item — actions, settlements and penalties with the regulator, date and amount where published. Every row links to its source.

Where does the Sanofi information come from?

Company profiles are sourced from neutral references: Wikipedia, official company websites and filings, and regulator records. Our own coverage is the regulatory history table and the case links below.

Affected by Sanofi products?

Check the case record and start a free review on the relevant case page: Depakine Valproate Class Action (Sanofi) →